1st Edition
Equity and Healthcare Reform in Developing Economies The Case of Turkey
1 Equity in healthcare services
The meaning and key concepts of equity in healthcare
Globalization, personalized medicines, and an increasing concern for equity in healthcare
Health system differences and equity in health system
Health trends and equity
Social inclusiveness and equity in healthcare
2 International comparison of equity in healthcare services
International comparison of equity in healthcare services
Health reforms and health equity
Current health system problems and increasing need to consider equity in health
3 Equity in health services and policy advice for developing countries
Equity in health interventions in developing countries
Equity in distribution of health financing in developing countries
Policy advice to improve equities in developing countries
4 Equity lessons learned from pharmerging countries
Characteristics of pharmerging countries
Brazil
China
India
Russia
Mexico
Thailand
5 Equity in health services in emerging markets similar to Turkey
Healthcare financing and affordability in the N-11 emerging markets
Healthcare financing and affordability for Turkey’s neighbors
Recommendations to build strong health systems in Southeastern Europe and Turkey
6 Health reform in Turkey and inclusive policies
Historical background of Turkish health reform
AKP’s health reform
Healthcare becomes focused policymaking area of AKP government
The changing direction of Turkish economy and need for equity analysis of redistributive policies
7 Measurement of the level of equity in healthcare services
Equity measurement in healthcare services
Index approaches
Curve approaches
8 Equity in pharmaceutical expenditures under health reform in Turkey
An overview of the level of OOP health expenditures and international comparison
Consumption of drugs (million boxes) and international comparison
Growth potential of pharmaceutical market and international comparison
Equity analysis of households’ pharmaceutical expenditures in Turkey for the years 2005–2015
9 Advice for health policymakers to consider equity in the distribution of pharmaceutical expenditures and pharmaceutical market design
Pharmaceutical market as an interactive policymaking area in healthcare
Turkey’s pharmaceutical policy reform and equity expenses
Advice for Turkish health policymakers to consider equity in pharmaceutical market design and price controls
Generic drug market design and the need for high-priced industrial policy strategy
Biography
Songül Çınaroğlu is a Doctor in Health Administration and Assistant Professor in the Faculty of Economics and Administrative Sciences in the Department of Health Care Management at Hacettepe University, Turkey. She is a former visiting researcher at the University of Michigan (Ann Arbor) and of the University of Alabama (Birmingham). Her main research interest is health economics, policy and outcomes research.
